Acta Scientific Gastrointestinal Disorders (ASGIS)(ISSN: 2582-1091)

Review Article Volume 5 Issue 4

Diabetes Mellitus, Constipation, and Fiber Intake

Fabiola Prado*

Department of Diabetes Education Program, Diabetcentro, Cuatemala

*Corresponding Author: Fabiola Prado, Department of Diabetes Education Program, Diabetcentro, Cuatemala.

Received: December 01, 2021; Published: March 04, 2022

Abstract

Dietary fiber is a term that includes the edible parts of plants or analogous carbohydrates resistant to digestion and absorption in the human small intestine with complete or partial fermentation in the large intestine. Functional fibers are isolated, non-digestible carbohydrates which have beneficial physiological effects in humans. Total fiber is the sum of dietary and functional fiber. Dietary fiber is important for human beings because it is associated with a normal gut microbiota. Gut microbes act upon dietary fiber to produce metabolites like short-chain fatty acids, which may be absorbed into the circulation and are thought to affect metabolic regulation processes. These fatty acids may also be a substrate for other gut microbes. Although increasing dietary fiber intake is a general recommendation for overall health as well as for constipation, there is a 30-year debate and strong controversy about the scientific evidence of its clinical benefits and about the type and amount of fiber to be prescribed in each case. This document analyzes the evidence about the types and mechanism of action of dietary fiber for managing constipation. We propose an algorithm of steps clinicians must have in mind when prescribing fiber supplements for people with type 2 diabetes mellitus with constipation.

Keywords: Dietary Fiber Intake; Constipation; Type 2 Diabetes Mellitus; Treatment Algorithm

References

  1. Sumida K., et al. “Constipation and incident CKD”. Journal of the American Society of Nephrology 4 (2017): 1248-1258.
  2. Myhrstad MCW., et al. “Dietary fiber, Gut Microbiota, and Metabolic Regulation - Current Status in Human Randomized Trials”. Nutrients3 (2020): 859.
  3. Patel S and Goyal A. “The current trends and future perspectives of prebiotics research: a review”. 3 Biotechnology2 (2012).
  4. Barboi OB., et al. “Effect of inulin in the treatment of irritable bowel syndrome with constipation (review)”. Experimental and Therapeutic Medicine 6 (2020): 185.
  5. McRorie JW and McKeown NM. “Understanding the Physics of Functional Fibers in the Gastrointestinal Tract: An Evidence-Based Approach to Resolving Enduring Misconceptions about Insoluble and Soluble Fiber”. Journal of the Academy of Nutrition and Dietetics 117 (2017): 251-264.
  6. U.S. Department of Agriculture and U.S. Department of Health and Human Services. “Dietary Guidelines for Americans 2020-2025” (2020).
  7. Joanne L Slavin. “Position of the American Dietetic Association. Health Implications of Dietary Fiber”. Journal of the American Dietetic Association10 (2008): 1716-1731.
  8. Hite AH., et al. “In the face of contradictory evidence; Report of the Dietary Guidelines for Americans Committee”. Nutrition 26 (2010): 915-924.
  9. Mahshid Dehghan., et al. “The Prospective Urban Rural Epidemiology Study Investigators. “Associations of fats and carbohydrate intake with cardiovascular diesase and mortality in 18 countries from 5 continents (PURE): a prospective cohort study”. The Lancet10107 (2017): 2050-2062.
  10. Victoria Miller., et al. “The Prospective Urban Rural Epidemiology (PURE) Study Investigators. “Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study”. The Lancet 390 (2017): 2037-2049.
  11. Kovalskys I., et al. “Latin American consumption of major food groups; Results from the ELANS Study”. PLoS ONE12 (2019): e0225101.
  12. Liska D., et al. “Narrative Review of Hydration and Selected Health Outcomes in the General Population”. Nutrients1 (2019): 70.
  13. Francis CY and Whorwell PJ. “Bran and irritable bowel syndrome: time for reappraisal”. Lancet8914 (1994): 39-40.
  14. Camiolleri M. “Diagnosis and Treatment of Irritable Bowel Syndrome: A Review”. JAMA9 (2021): 865-877.
  15. Basson MD. “Constipation” (2020).
  16. Kuznik E., et al. “Diabetic autonomic neuropathy of the gastrointestinal tract”. Przeglad Gastroenterologiczny 2 (2020): 89-93.
  17. Piper MS and Saad RJ. “Diabetes Mellitus and the Colon”. Current Treatment Options in Gastroenterology 4 (2017): 460-474.
  18. Fragakis a., et al. “Association between Drug Usage and Constipation in the Elderly Population of Greater Western Sydney Australia”. International Journal of Environmental Research and Public Health 226 (2018).
  19. PAR Gurwitz JH. “The prescribing cascade revisited”. The Lancet10081 (2017): 1778-1780.

Citation

Citation: Fabiola Prado. “Diabetes Mellitus, Constipation, and Fiber Intake". Acta Scientific Gastrointestinal Disorders 5.4 (2022): 07-13.

Copyright

Copyright: © 2022 Fabiola Prado. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US